Qube Research & Technologies (QRT)
IMUX icon

Qube Research & Technologies (QRT)’s Immunic IMUX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,146
Closed -$124K – 3761
2026
Q1 		$124K Buy
+11,146
New +$99.8K ﹤0.01% 3039
2025
Q4 		– Sell
-3,267
Closed -$28.8K – 3860
2025
Q3 		$28.8K Buy
+3,267
New +$28.8K ﹤0.01% 3256
2025
Q2 		– Sell
-3,499
Closed -$38.1K – 3737
2025
Q1 		$38.1K Sell
3,499
-13,077
-79% -$141K ﹤0.01% 3155
2024
Q4 		$166K Sell
16,576
-920
-5% -$11.6K ﹤0.01% 2880
2024
Q3 		$289K Buy
17,496
+17,491
+349,820% +$249K ﹤0.01% 2441
2024
Q2 		$56 Buy
+5
New +$62 ﹤0.01% 3495
2024
Q1 		– Sell
-6
Closed -$87 – 4665
2023
Q4 		$87 Hold
6
– – ﹤0.01% 4034
2023
Q3 		$85 Buy
+6
New +$115 ﹤0.01% 3776
2022
Q4 		– Sell
-1,434
Closed -$45K – 2722
2022
Q3 		$45K Sell
1,434
-137
-9% -$5.73K ﹤0.01% 2158
2022
Q2 		$55K Buy
+1,571
New +$101K ﹤0.01% 2101

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMUX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Immunic (IMUX) in Q2 2026, closing a stake of 11,146 shares — an estimated $124K sold.

Qube Research & Technologies (QRT) first reported a position in IMUX in Q2 2022 and held it in 10 quarters. The position peaked at $289K in Q3 2024. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11,146 Immunic shares in Q2 2026, an estimated $124K.
  • Qube Research & Technologies (QRT) first reported a position in Immunic in Q2 2022 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Immunic position peaked at $289K in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.